Your browser doesn't support javascript.
loading
Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs.
Lavin, Richard C; Johnson, Calvin; Ahn, Yong-Mo; Kremiller, Kyle M; Sherwood, Matthew; Patel, Jimmy S; Pan, Yan; Russo, Riccardo; MacGilvary, Nathan J; Giacalone, David; Kevorkian, Yuzo L; Zimmerman, Matthew D; Glickman, J Fraser; Freundlich, Joel S; Tan, Shumin.
Affiliation
  • Lavin RC; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Johnson C; Graduate Program in Molecular Microbiology, Graduate School of Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America.
  • Ahn YM; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Kremiller KM; Department of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey, United States of America.
  • Sherwood M; Department of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey, United States of America.
  • Patel JS; Department of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey, United States of America.
  • Pan Y; Department of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey, United States of America.
  • Russo R; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, United States of America.
  • MacGilvary NJ; Division of Infectious Disease, Department of Medicine and the Ruy V. Lourenco Center for the Study of Emerging and Re-emerging Pathogens, Rutgers University-New Jersey Medical School, Newark, New Jersey, United States of America.
  • Giacalone D; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Kevorkian YL; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Zimmerman MD; Graduate Program in Molecular Microbiology, Graduate School of Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America.
  • Glickman JF; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Freundlich JS; Graduate Program in Molecular Microbiology, Graduate School of Biomedical Sciences, Tufts University, Boston, Massachusetts, United States of America.
  • Tan S; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, United States of America.
PLoS Biol ; 19(7): e3001355, 2021 07.
Article in En | MEDLINE | ID: mdl-34319985
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Development / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS Biol Journal subject: BIOLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Development / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS Biol Journal subject: BIOLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos